Alliance Pharma (LON:APH) Shares Pass Above 200 Day Moving Average of $37.91

Alliance Pharma plc (LON:APHGet Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 37.91 ($0.48) and traded as high as GBX 41.70 ($0.53). Alliance Pharma shares last traded at GBX 38.60 ($0.49), with a volume of 4,079,249 shares.

Analyst Ratings Changes

Separately, Royal Bank of Canada lowered their price objective on Alliance Pharma from GBX 65 ($0.83) to GBX 60 ($0.76) and set an “outperform” rating for the company in a research report on Wednesday, January 31st.

Check Out Our Latest Stock Analysis on APH

Alliance Pharma Stock Up 2.1 %

The company has a market capitalization of £212.92 million, a P/E ratio of -3,860.00, a P/E/G ratio of 1.04 and a beta of 0.61. The stock has a 50-day moving average price of GBX 36.17 and a 200-day moving average price of GBX 37.91. The company has a debt-to-equity ratio of 45.00, a current ratio of 1.93 and a quick ratio of 1.42.

About Alliance Pharma

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Further Reading

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.